Related Experiment Video
Updated: Apr 23, 2026

10:05
Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice
Published on: March 20, 2017
11.7K
[Obesity, bariatric surgery and future fertility]
Harefuah
|October 8, 2014
Summary
Bariatric surgery improves fertility and pregnancy outcomes in obese women. However, careful nutritional monitoring is crucial during pregnancy after surgery to prevent complications and ensure healthy fetal growth.
Area of Science:
- Reproductive Endocrinology
- Bariatric Surgery
- Maternal-Fetal Medicine
Context:
- Obesity is a global health issue with significant impacts on reproductive health, including infertility and pregnancy complications.
- Obesity is linked to comorbidities like diabetes, hypertension, dyslipidemia, and cardiovascular disease.
- Reproductive challenges in obese women include infertility, miscarriages, and increased pregnancy complications.
Purpose:
- To review the benefits of bariatric surgery on fertility and pregnancy outcomes in obese women.
- To discuss the safety and risks associated with pregnancy following bariatric surgery.
- To highlight the importance of nutritional status and peri-conceptional surveillance.
Summary:
- Bariatric surgery enhances ovulatory cycles and spontaneous conception rates in obese women.
- Pregnancy post-bariatric surgery is generally safe with fewer complications, but risks of preterm birth and small for gestational age infants persist.
- Nutritional balance, rather than strict timing post-surgery, is key for optimal pregnancy outcomes.
- Close monitoring during pregnancy is essential to manage nutritional deficiencies and fetal growth abnormalities.
Impact:
- Bariatric surgery offers a viable option for improving reproductive health in severely obese women.
- Understanding the risks and benefits aids in counseling patients considering pregnancy after bariatric procedures.
- Emphasizes the critical role of nutritional management in successful pregnancies following bariatric surgery.
Related Concept Videos
Obesity
1.5K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
430
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
430
Drug Dosing: Obese Patients
357
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
357
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
317
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
317
Infertility in Females
4.8K
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
Endometriosis, a condition characterized by abnormal growth of...
4.8K
Infertility in Males
645
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
645

